Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Completed · Phase 3 · Has a placebo group

Conditions studied: Symptomatic Neurogenic Orthostatic Hypotension (NOH), Non-diabetic Neuropathy, Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency

In brief

The purpose of this study is to see whether droxidopa is effective in treating symptoms of neurogenic orthostatic hypotension in patients with Primary Autonomic Failure (Pure Autonomic Failure, Multiple System Atrophy, Parkinson's Disease), Non-diabetic neuropathy, or Beta Hydroxylase deficiency.

Key facts

Study ID
NCT00633880
Run by
Chelsea Therapeutics
People needed
181
Starts
2008-01-01
Expected to finish
2009-09-01
Last updated by the study team
2014-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.